Marshall Milliken
Investor @ Myodetox
San Francisco, United States
Marshall Milliken is a startup investor at Myodetox in San Francisco. Marshall is a Partner at Simon Equity Partners (“SEP”) and joined the firm in 2014. Prior to joining SEP, Marshall was an investment banker with Piper Jaffray, a leading middle-market investment bank. At Piper Jaffray, Marshall was a member of the firm’s consumer and retail team, where he worked directly with companies and management teams acrossthe apparel and retail, consumer products, food, beverage, wellness and restaurant verticals. Marshall began his career in investment banking at BB&T Capital Markets, working as a generalist in the firm’s M&A group. Marshall currently serves on the Board of Directors for Equator Coffee, Guideboat Co., Wise Sons and Boon Supply Co. Marshall earned his B.S. degree in Finance from The Wake Forest University School of Business.
Last updated:
For AI agents: llms.txt
About Myodetox
Myodetox is a personal health company that specializes in physical therapist & fitness development service.
Myodetox Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Marshall Milliken
Investor
|
|||
Scott Marcaccio
Founder & CEO
|
|||
Vinh Pham
Chief Creative Officer, Co-Founder & Co-Owner
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
